HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susumu Ishida Selected Research

Type 1 Angiotensin Receptor

1/2013Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease.
1/2012Receptor-associated prorenin system in the pathogenesis of retinal diseases.
5/2009Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
12/2008(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.
10/2008Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
5/2008Pathologic roles of prorenin and (pro)renin receptor in the eye.
9/2007Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
12/2006Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
10/2006Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
8/2005Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susumu Ishida Research Topics

Disease

53Inflammation (Inflammations)
04/2022 - 02/2004
44Diabetic Retinopathy (Retinopathy, Diabetic)
04/2022 - 05/2003
28Neoplasms (Cancer)
12/2022 - 12/2010
25Uveitis
05/2022 - 06/2004
22Choroidal Neovascularization
07/2020 - 10/2006
19Macular Degeneration (Age-Related Maculopathy)
01/2022 - 01/2007
12Epiretinal Membrane (Epiretinal Membranes)
01/2017 - 02/2002
10Hypoxia (Hypoxemia)
07/2021 - 08/2003
10Cataract (Cataracts)
07/2020 - 11/2004
10Retinal Perforations
01/2017 - 02/2002
9Retinal Detachment (Retinal Detachments)
09/2022 - 02/2002
9Glaucoma
01/2022 - 01/2008
7Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
05/2022 - 04/2015
7Fibrosis (Cirrhosis)
01/2021 - 01/2013
7White Dot Syndromes
06/2019 - 01/2012
7Macular Edema
11/2017 - 06/2004
6Retinal Hemorrhage
04/2022 - 01/2011
5Lymphoma (Lymphomas)
10/2022 - 06/2004
5Neovascular Glaucoma
03/2022 - 01/2008
5Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2022 - 08/2012
5Retinal Neovascularization
01/2016 - 08/2003
5Pathologic Neovascularization
08/2013 - 06/2003
4Retinal Degeneration
09/2022 - 05/2008
4Retinal Vein Occlusion
03/2022 - 05/2009
4Ischemia
03/2022 - 06/2003
4Cicatrix (Scar)
03/2022 - 10/2004
4Ganglion Cysts (Ganglion)
09/2021 - 09/2012
4Melanoma (Melanoma, Malignant)
07/2021 - 11/2011
4Hemorrhage
05/2019 - 01/2008
4Wounds and Injuries (Trauma)
06/2017 - 08/2007
4Retinal Vasculitis
01/2015 - 09/2012
3Intraocular Lymphoma
10/2022 - 06/2004
3Sarcoidosis (Schaumann Disease)
05/2022 - 01/2010
3Vitreous Hemorrhage
03/2022 - 09/2012
3Vitreous Detachment (Posterior Vitreous Detachment)
01/2018 - 02/2007
3Burns
05/2017 - 05/2008
3Retinal Diseases
01/2017 - 03/2009
3Atopic Dermatitis (Atopic Eczema)
01/2017 - 10/2005
3Pterygium
08/2016 - 01/2011
3Atrophy
01/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

59Retinaldehyde (Retinal)IBA
09/2022 - 02/2002
34Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2003
13Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2006
13Adrenal Cortex Hormones (Corticosteroids)IBA
08/2019 - 05/2009
13EndotoxinsIBA
01/2014 - 08/2005
11ReninIBA
07/2020 - 06/2006
11Type 1 Angiotensin ReceptorIBA
01/2013 - 03/2005
10Prorenin ReceptorIBA
09/2019 - 06/2006
7Prednisolone (Predate)FDA LinkGeneric
03/2022 - 09/2012
7Galectin 1 (LGALS1)IBA
01/2021 - 12/2015
6Fluorescein (Funduscein)FDA LinkGeneric
09/2022 - 07/2005
6Crystallins (Crystallin)IBA
04/2022 - 10/2011
6Indocyanine Green (Cardio-Green)FDA LinkGeneric
09/2021 - 02/2002
6Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2021 - 02/2004
6Therapeutic UsesIBA
10/2020 - 12/2006
6Bevacizumab (Avastin)FDA Link
03/2018 - 01/2011
6Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2009 - 05/2003
5Advanced Glycation End ProductsIBA
04/2022 - 02/2007
5AntibodiesIBA
10/2021 - 12/2009
5Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2020 - 02/2007
5Biological ProductsIBA
01/2019 - 05/2012
5CytokinesIBA
06/2017 - 03/2007
4Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2010
4Acrolein (Aqualin)IBA
01/2021 - 01/2017
4Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2020 - 12/2015
4Ophthalmic Solutions (Eye Drops)IBA
11/2019 - 11/2011
4InterleukinsIBA
10/2019 - 06/2007
4Peptides (Polypeptides)IBA
12/2016 - 06/2006
4Oxygen (Dioxygen)IBA
08/2013 - 11/2004
4Cell Adhesion MoleculesIBA
01/2013 - 03/2009
4Telmisartan (Micardis)FDA Link
05/2009 - 03/2005
4Interleukin-6 (Interleukin 6)IBA
09/2008 - 06/2004
3Coloring Agents (Dyes)IBA
09/2022 - 05/2019
3Pharmaceutical PreparationsIBA
09/2022 - 09/2016
3SteroidsIBA
02/2022 - 11/2016
3Vascular Endothelial Growth Factor CIBA
07/2021 - 02/2013
3Interleukin-10 (Interleukin 10)IBA
05/2021 - 06/2004
3Protein Isoforms (Isoforms)IBA
01/2021 - 05/2003
3EnzymesIBA
07/2020 - 01/2013
3AldehydesIBA
01/2020 - 01/2017
3InterferonsIBA
11/2019 - 11/2011
3ParaffinIBA
06/2017 - 12/2009
3Infliximab (Remicade)FDA Link
01/2016 - 07/2012
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2013 - 10/2005
3Monocyte Chemoattractant ProteinsIBA
01/2013 - 06/2007
3LuteinIBA
05/2012 - 12/2007
3ResveratrolIBA
11/2011 - 07/2009

Therapy/Procedure

28Therapeutics
06/2022 - 01/2011
25Vitrectomy
04/2022 - 02/2002
22Lasers (Laser)
10/2020 - 04/2002
7Intravitreal Injections
07/2020 - 01/2011
6Trabeculectomy (Trabeculoplasty)
01/2022 - 08/2012
5Drug Therapy (Chemotherapy)
04/2022 - 01/2014
5Light Coagulation
05/2019 - 01/2008
4Sutures (Suture)
01/2022 - 08/2012
4Radiotherapy
07/2020 - 05/2011
4Slit Lamp
01/2020 - 12/2010
4Intraocular Lens Implantation
01/2017 - 10/2005
4Cannula
07/2008 - 11/2004
3Injections
01/2017 - 05/2003